![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » TGA Introduces New Requirements for Sponsors of ‘Sartan’ Blood Pressure Meds
TGA Introduces New Requirements for Sponsors of ‘Sartan’ Blood Pressure Meds
September 24, 2019
Australia’s Therapeutic Goods Administration released new requirements for ‘sartan’ blood pressure medicines.
TGA urged sponsors to take measures to avoid the presence of N-nitroso impurities in their medicines and to implement rigorous testing to identify the presence of the impurities.
The agency is providing a two-year transition period for sponsors to make changes to their manufacturing processes and to implement adequate testing methods.
Upcoming Events
-
21Oct